Inhaled corticosteroid therapy for patients with persistent asthma: Learnings from studies of inhaled budesonide

Allergy and Asthma Proceedings

Volumn 30, Issue 3, 2009, Pages 217-228

  Chipps, Bradley E ^a  

^a Capital Allergy and Respiratory Disease Center   (United States)

Author keywords

Asthma control; Budesonide; Combination therapy; Formoterol; Inhaled corticosteroids; Long acting beta2 adrenergic agonist; Mild persistent asthma; Single controller therapy

Indexed keywords

BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; BUDESONIDE; CORTICOSTEROID; NEDOCROMIL; PLACEBO; ZAFIRLUKAST; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; BRONCHODILATING AGENT; ETHANOLAMINE DERIVATIVE; FORMOTEROL; GLUCOCORTICOID;

ARTICLE; ASTHMA; CHILD; CORTICOSTEROID THERAPY; DISEASE COURSE; DISEASE SEVERITY; DRUG EFFICACY; FORCED EXPIRATORY VOLUME; HUMAN; RISK ASSESSMENT; TREATMENT OUTCOME; CLINICAL TRIAL; DRUG COMBINATION; INHALATIONAL DRUG ADMINISTRATION; KAPLAN MEIER METHOD; REVIEW;

ADMINISTRATION, INHALATION; ADRENERGIC BETA-AGONISTS; ASTHMA; BRONCHODILATOR AGENTS; BUDESONIDE; CLINICAL TRIALS AS TOPIC; DRUG THERAPY, COMBINATION; ETHANOLAMINES; GLUCOCORTICOIDS; HUMANS; KAPLAN-MEIERS ESTIMATE;

EID: 68249153849     PISSN: 10885412     EISSN: 15396304     Source Type: Journal    
DOI: 10.2500/aap.2009.30.3201     Document Type: Article

References (31)

1. National Heart, Lung, Blood Institute (NHLBI). National Asthma Education and Prevention Program expert panel report 3: Guidelines for the diagnosis and management of asthma. Full Report 2007, NHLBI publication no. 08-4051. Available online at www.nhlbi.nih.gov/guidelines/asthma/asthgdln.pdf; last accessed April 2008.
2. Global Initiative for Asthma (GINA). Global strategy for asthma management and prevention. Updated 2007. Available online at www.ginasthma.com; last accessed December 2007.
3. Schatz M, Zeiger RS, Vollmer WM, et al. Determinants of future long-term asthma control. J Allergy Clin Immunol 118:1048-1053, 2006.
4. Desfougeres JL, Sohier B, Freedman D, et al. Perception of asthma control by patients: Results of a survey in 5 European countries. Eur Respir J 30(suppl):1590, 2007.
5. Boushey HA, Sorkness CA, King TS, et al. Daily versus as-needed corticosteroids for mild persistent asthma. N Engl J Med 352:1519-1528, 2005.
6. Salmeron S, Liard R, Elkharrat D, et al. Asthma severity and adequacy of management in accident and emergency departments in France: A prospective study. Lancet 358:629-635, 2001.
7. Warman KL, Silver EJ, and Stein REK. Asthma symptoms, morbidity, and antiinflammatory use in inner-city children. Pediatrics 108:277-282, 2001.
8. Pauwels RA, Pedersen S, Busse WW, et al. Early intervention with budesonide in mild persistent asthma: A randomised, double-blind trial. Lancet 361:1071-1076, 2003.
9. Busse WW, Pedersen S, Pauwels RA, et al. The Inhaled Steroid Treatment As Regular Therapy in Early Asthma (START) study 5-year follow-up: Effectiveness of early intervention with budesonide in mild persistent asthma. J Allergy Clin Immunol 121:1167-1174, 2008.
10. The Childhood Asthma Management Program Research Group. Long-term effects of budesonide or nedocromil in children with asthma. N Engl J Med 343:1054-1063, 2000.
11. Bisgaard H, Hermansen MN, Loland L, et al. Intermittent inhaled corticosteroids in infants with episodic wheezing. N Engl J Med 354:1998-2005, 2006.
12. O'Byrne PM, Barnes PJ, Rodriguez-Roisin R, et al. Low dose inhaled budesonide and formoterol in mild persistent asthma: The OPTIMA randomized trial. Am J Respir Crit Care Med 164:1392-1397, 2001.
13. Pauwels RA, Löfdahl C-G, Postma DS, et al. Effect of inhaled formoterol and budesonide on exacerbations of asthma. N Engl J Med 337:1405-1411, 1997.
14. Pauwels RA, Busse WW, O'Byrne PM, et al. The inhaled Steroid Treatment as Regular Therapy in early asthma (START) study: Rationale and design. Control Clin Trials 22:405-419, 2001.
15. ISI Web of Knowldege. Web of science. Database search engine. Available online at www.aaps.isisknowlege/com/CitedFullRecor.do?product; last accessed August 2008.
16. Agertoft L, and Pedersen S. Effects of long-term treatment with an inhaled corticosteroid on growth and pulmonary function in asthmatic children. Respir Med 88:373-381, 1994.
17. Haahtela T, Jarvinen M, Kava T, et al. Effects of reducing or discontinuing inhaled budesonide in patients with mild asthma. N Engl J Med 331:700-705, 1994.
18. Selroos O, Pietinalho A, Löfroos A-B, and Riska H. Effect of early vs late intervention with inhaled corticosteroids in asthma. Chest 108:1228-1234, 1995.
19. Sullivan SD, Buxton M, Andersson LF, et al. Cost-effectiveness analysis of early intervention with budesonide in mild persistent asthma. J Allergy Clin Immunol 112:1229-1236, 2003.
20. Chen Y-Z, Busse WW, Pedersen S, et al. Early intervention of recent onset mild persistent asthma in children aged under 11 yrs: The Steroid Treatment As Regular Therapy in early asthma (START) trial. Pediatr Allergy Immunol 17:7-13, 2006.
21. Weiss K, Buxton M, Andersson FL, et al. Cost-effectiveness of early intervention with once-daily budesonide in children with mild persistent asthma: Results from the START study. Pediatr Allergy Immunol 17:21-27, 2006.
22. Silverman M, Sheffer AL, Díaz PV, et al. Safety and tolerability of inhaled budesonide in children in the Steroid Treatment As Regular Therapy in early asthma (START) trial. Pediatr Allergy Immunol 17:14-20, 2006.
23. Lange P, Parner J, Vestbo J, et al. A 15-year follow-up study of ventilatory function in adults with asthma. N Engl J Med 339:1194-1200, 1998.
24. Peat JK, Woolcock AJ, and Cullen K. Rate of decline of lung function in subjects with asthma. Eur J Respir Dis 70:171-179, 1987.
25. O'Byrne PM, Pedersen S, Busse WW, et al. Effects of early intervention with inhaled budesonide on lung function in newly diagnosed asthma. Chest 129:1478-1485, 2006.
26. Agertoft L, and Pedersen S. Effect of long-term treatment with inhaled budesonide on adult height in children with asthma. N Engl J Med 343:1064-1069, 2000.
27. Strunk RC, and Childhood Asthma Management Program Research Group. Childhood Asthma Management Program: Lessons learned. J Allergy Clin Immunol 119:36-42, 2007.
28. O'Byrne PM. Daily inhaled corticosteroid treatment should be prescribed for mild persistent asthma. Pro Am J Respir Crit Care Med 172:410-412, discussion 415-416, 2005.
29. Mansfield LE. The future of the long-acting beta-adrenergic bronchodilators in the treatment of asthma. Allergy Asthma Proc 29:103-108, 2008.
30. Lang DM, and Davis RS. The long-acting beta-agonist controversy: A clinical dilemma. Allergy Asthma Proc 28:136-144, 2007.
31. Peters ST, Prenner BM, Mezzanotte WS, et al. Long-term safety and asthma control with budesonide/formoterol versus budesonide pressurized metered-dose inhaler (pMDI) in asthma patients. Allergy Asthma Proc 29:499-516, 2008.